National Perinatal Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, OX3 7LF, UK.
Division of Physical and Mental Health, Norwegian Institute of Public Health, 5015, Bergen, Norway.
Nat Commun. 2024 Apr 15;15(1):3234. doi: 10.1038/s41467-024-47181-z.
There are few population-based studies of sufficient size and follow-up duration to have reliably assessed perinatal outcomes for pregnant women hospitalised with SARS-CoV-2 infection. The United Kingdom Obstetric Surveillance System (UKOSS) covers all 194 consultant-led UK maternity units and included all pregnant women admitted to hospital with an ongoing SARS-CoV-2 infection. Here we show that in this large national cohort comprising two years' active surveillance over four SARS-CoV-2 variant periods and with near complete follow-up of pregnancy outcomes for 16,627 included women, severe perinatal outcomes were more common in women with moderate to severe COVID-19, during the delta dominant period and among unvaccinated women. We provide strong evidence to recommend continuous surveillance of pregnancy outcomes in future pandemics and to continue to recommend SARS-CoV-2 vaccination in pregnancy to protect both mothers and babies.
针对因感染 SARS-CoV-2 而住院的孕妇,围产期结局的评估,基于人群的研究数量较少,随访时间也不足够长,难以提供可靠的结果。英国产科监测系统(UKOSS)涵盖了英国所有 194 家由顾问主导的产科单位,纳入了所有因持续 SARS-CoV-2 感染而住院的孕妇。本研究显示,在这一大规模的全国队列中,对四种 SARS-CoV-2 变异株流行期的两年主动监测,以及对 16627 名纳入女性的妊娠结局进行了近乎完整的随访,在德尔塔主导流行期和未接种疫苗的女性中,中度至重度 COVID-19 的孕妇更易发生严重的围产期结局。本研究为未来大流行期间持续监测妊娠结局提供了有力证据,并建议继续在妊娠期间推荐 SARS-CoV-2 疫苗接种,以保护母婴。